Arora et al. found that miR-506 was down-regulated in breast cancer tissues and suggested that miR-506 regulates breast cancer epithelial-mesenchymal transition by targeting Vimentin, Snai2, and CD151 [15]. Here, VIM is linked to breast cancer.